Oncology Updates: Lung, Breast, Liver, Colorectal & More Breakthroughs
Автор: LucidQuest
Загружено: Прямой эфир состоялся 15 апр. 2025 г.
Просмотров: 64 просмотра
This week in oncology, Imfinzi and IMDELLTRA advance small cell lung cancer care with new survival data and regulatory approvals. Rybrevant’s subcutaneous form gains EU approval, while CureVac launches a Phase 1 trial in squamous NSCLC. Opdivo + Yervoy earns dual FDA approvals for liver and colorectal cancers, showing strong survival benefits. Breast cancer drug Datroway is approved in the EU. Vitrakvi secures full FDA approval for NTRK fusion tumors, and new trials for relacorilant and ALX2004 are underway. Innovation accelerates across tumor types.

Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: